US 8105598
Human monoclonal antibodies that specifically bind IGF-II
granted A61KA61K2039/505A61P
Quick answer
US patent 8105598 (Human monoclonal antibodies that specifically bind IGF-II) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00, A61P35/04